Millennium Management
NEPH icon

Millennium Management’s Nephros NEPH Stock Holding History

Millennium Management’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13,424
Closed -$118K – 7178
2021
Q3 		$118K Sell
13,424
-1,599
-11% -$13.9K ﹤0.01% 6361
2021
Q2 		$156K Sell
15,023
-3,886
-21% -$32.4K ﹤0.01% 6108
2021
Q1 		$126K Sell
18,909
-2,200
-10% -$17.3K ﹤0.01% 5644
2020
Q4 		$181K Sell
21,109
-22,877
-52% -$154K ﹤0.01% 4860
2020
Q3 		$318 Buy
43,986
+25,065
+132% +$183K ﹤0.01% 3812
2020
Q2 		$159K Sell
18,921
-1,091
-5% -$8.64K ﹤0.01% 3900
2020
Q1 		$122K Sell
20,012
-2,489
-11% -$21.1K ﹤0.01% 3508
2019
Q4 		$224K Sell
22,501
-16,020
-42% -$143K ﹤0.01% 3818
2019
Q3 		$313K Buy
+38,521
New +$282K ﹤0.01% 3544

Other funds holding NEPH

CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management's NEPH Position: Q4 2021 in Review

Millennium Management sold out of Nephros (NEPH) in Q4 2021, closing a stake of 13,424 shares — an estimated $118K sold.

Millennium Management first reported a position in NEPH in Q3 2019 and held it in 9 quarters. The position peaked at $313K in Q3 2019. 17 funds tracked by Wall St. Rank hold NEPH as of Q4 2021.

  • Millennium Management reported no remaining Nephros position as of Q4 2021 after selling out during the quarter.
  • Millennium Management sold 13,424 Nephros shares in Q4 2021, an estimated $118K.
  • Millennium Management first reported a position in Nephros in Q3 2019 and held it in 9 quarters.
  • Millennium Management's Nephros position peaked at $313K in Q3 2019.
  • 17 funds tracked by Wall St. Rank held Nephros as of Q4 2021.

Based on Millennium Management's 13F filing for Q4 2021, filed 14 Feb 2022.